Compositions comprising oxophosphonate-based metalloproteinase inhibitors
US7101864B1 · kind B1 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2000 |
| Grant date | Sep 5, 2006 |
| Priority date | — |
| Expiry date | Dec 27, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions useful for treating or controlling disease states or conditions associated with zinc containing proteinases, especially metalloproteinases. The active ingredient in these compositions is an alpha-oxo- or alpha-thixophosphpnate of formula (I). Out of the phosphonates of formula (I), some are known and others are new. The novel compounds constitute another aspect of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.